Pharmabiz

Mirum Pharma inks agreement to acquire biotech company, Bluejay Therapeutics for up to $820 million

Mirum Pharma inks agreement to acquire biotech company, Bluejay Therapeutics for up to $820 million: Foster City, California Tuesday, December 9, 2025, 14:00 Hrs [IST] Mirum Pharm ...
Pharmabiz

IPC to come out with10th edition of IP to further strengthen standards of drugs in India

IPC to come out with10th edition of IP to further strengthen standards of drugs in India: Shardul Nautiyal, Mumbai Tuesday, ...
Pharmabiz

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces CMSF in CDKL5 deficiency disorder

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces CMSF in CDKL5 deficiency disorder: Brussels, Belgium Tuesday, December 9, 2 ...
Pharmabiz

L’Oréal to acquire an additional 10% stake in Galderma from Sunshine SwissCo GmbH

L’Oréal to acquire an additional 10% stake in Galderma from Sunshine SwissCo GmbH: Zug, Switzerland Tuesday, December 9, 2025, 12:00 Hrs [IST] Galderma Group AG, the pure-play ...
Pharmabiz

MOC’s first neighbourhood cancer treatment facility inaugurated in Delhi

MOC’s first neighbourhood cancer treatment facility inaugurated in Delhi: Our Bureau, Mumbai Monday, December 8, 2025, 14:45 ...
Pharmabiz

Hutchmed announces expanded coverage on National Reimbursement Drug List and inclusion in the first Commercial Insurance Drug List in China

Hutchmed announces expanded coverage on National Reimbursement Drug List and inclusion in the first Commercial Insurance Drug List in China: Hong Kong, Shanghai Tuesday, December ...
Pharmabiz

Chugai Pharma announces 48-week NIHONBASHI phase III study results presented at JRVS meeting show that Vabysmo sustained vision improvements in Japanese patients with angioid ...

Chugai Pharma announces 48-week NIHONBASHI phase III study results presented at JRVS meeting show that Vabysmo sustained vision improvements in Japanese patients with angioid streaks ...
Pharmabiz

Boehringer Ingelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development

Boehringer Ingelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development: Ingelheim, Germany Tuesday, December 9, 2025, 09:00 H ...
Pharmabiz

Lack of financial assistance, technical expertise mar MSMEs prospects to meet revised Schedule M deadline

Lack of financial assistance, technical expertise mar MSMEs prospects to meet revised Schedule M deadline: Shardul Nautiyal, Mumbai Tuesday, December 9, 2025, 08:00 Hrs [IST] Indu ...
Pharmabiz

Shift in India’s PV from monitoring to redressal uncovers infrastructural & systemic gap: Dr Jagashetty

Shift in India’s PV from monitoring to redressal uncovers infrastructural & systemic gap: Dr Jagashetty: Nandita Vijayasimha, Bengaluru Tuesday, December 9, 2025, 08:00 Hrs [IST ...
Pharmabiz

Over 1,000 industry leaders to converge in Bhubaneswar for Odisha Pharma Summit on December 16

Over 1,000 industry leaders to converge in Bhubaneswar for Odisha Pharma Summit on December 16: Peethaambaran Kunnathoor, Chennai Tuesday, December 9, 2025, 08:00 Hrs [IST] The mu ...
Pharmabiz

CDSCO launches new online risk classification module for medical devices to simplify approval procedures

CDSCO launches new online risk classification module for medical devices to simplify approval procedures: Gireesh Babu, New Delhi Tuesday, December 9, 2025, 08:00 Hrs [IST] The Ce ...